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Introduction
Chagas disease is a major health problem in Latin America and an increasing threat in other countries that are non-endemic for Trypanosoma cruzi infection [1] [2] [3] [4] . The relevance of T cell-mediated immunity in controlling T. cruzi infection has been demonstrated in human T. cruzi infections and in experimental models [5] [6] [7] [8] [9] .
Individuals chronically infected with T. cruzi-have several indicators of T-cell exhaustion. A major finding was an overall low level of detectable T. cruzi-specific T cells and a predominance of single cytokine interferon (IFN)-γ only-producing T cells in the circulation of subjects with long-term T. cruzi infections [10] [11] [12] . Other feature of immune exhaustion of T cells in chronic Chagas disease is the expression of cytotoxic T lymphocyte antigen 4 by IFN-γ-producing CD4 + T cells in response to T. cruzi [13] and in the total T-cell compartment [13] [14] [15] .
CTLA-4 expression was also observed in CD3 + T lymphocytes infiltrating the heart tissues of chronically infected subjects with severe myocarditis [13] . These findings suggest that parasite persistence induces overexpression of inhibitory receptors that might regulate deleterious consequences of a sustained immune response but also dampens the parasite-specific T-cell responses necessary for parasite control. Interleukin-7 (IL-7) plays an important role in the maintenance of naïve and memory T cells by homeostatic mechanisms [16] . The IL-7 cell-surface receptor (IL-7R) comprises two chains, namely, the specific IL-7Rα (CD127) chain and the common γ-chain (CD132 or γc) [17] . The regulation of each chain is different; CD127 is downregulated, whereas the CD132 chain is rapidly upregulated upon T-cell activation [18] . Soluble IL-7R (sCD127) binds to IL-7 with an affinity similar to that of membrane-bound IL-7R [19] , leading to sIL-7R-mediated inhibition of IL-7 signaling in T cells [20] [21] . Inflammation perturbs the IL-7 axis, promoting senescence and exhaustion [22] [23] .
In a previous study, we found that chronic Chagas disease patients with severe cardiomyopathy have impaired function of IL-7R in total T cells [24] . Here, we sought to investigate whether the ability of T cells to produce IFN-γ in response to T. cruzi antigens was associated with the expression and function of IL-7R, with serum concentrations of the soluble form of IL-7R, STAT5 signaling, and inflammatory cytokines in chronic Chagas disease subjects with different degrees of cardiac dysfunction. In addition, in vitro treatment of PBMCs with IL-7 or IL-27 to enhance T. cruzi-specific IFN-γ production was evaluated. We showed that the ability of T cells to secrete IFN-γ in response to T. cruzi was associated with a functional IL-7/IL-7R signaling pathway in memory T cells, low levels of sCD127 and enhanced basal expression of Bcl-2 on T cells.
Materials and methods

Ethics statement
This study was approved by the Institutional Review Board of the Hospital Interzonal General de Agudos Eva Perón. All patients signed informed consent forms prior to inclusion in the study.
Selection of study population
T. cruzi-infected subjects were recruited at the Chagas Disease Unit Cardiology Department, Hospital Interzonal General de Agudos Eva Perón, Buenos Aires, Argentina. T. cruzi infection was determined with indirect immunofluorescence assays, hemagglutination and ELISA tests [25] . Patients positive in at least two of these tests were considered to be infected. Subjects were clinically evaluated and grouped according to a modified version of the Kuschnir grading system [26] : Group 0 (G0), seropositive individuals exhibiting a normal electrocardiogram (ECG) and normal echocardiograph; Group 1 (G1), seropositive individuals with a normal echocardiograph but ECG abnormalities; Group 2 (G2), seropositive individuals with ECG abnormalities and heart enlargement; and Group 3 (G3), seropositive individuals with ECG abnormalities, heart enlargement and clinical or radiological evidence of heart failure. These individuals were originally infected while living in areas where T. cruzi infection was endemic but had lived in an area where T. cruzi infection was not endemic for an average of 30 years. Two patients both in the G2 clinical stages had been treated with benznidazole six years prior to inclusion in this study. The serologic titers against T. cruzi did not decrease after treatment and in one of them the clinical stage changed from G1 to G2 after benznidazole administration, supporting that treatment was not successful in these two patients. Healthy subjects from Buenos Aires that have always resided in non-endemic areas and with negative serology for T. cruzi infection served as the uninfected group (UI). The primary characteristics of the study population are summarized in Table 1 . T. cruzi-infected patients and uninfected controls with hypertension, ischemic heart disease, cancer, HIV infection, syphilis, diabetes, arthritis or serious allergies were excluded from this study.
Collection of peripheral blood mononuclear cells (PBMCs) and sera
Approximately 50 mL of blood was drawn by venipuncture into heparinized tubes (Vacutainer, BD Biosciences). PBMCs were isolated by density gradient centrifugation with FicollHypaque medium (Amersham) and resuspended in a volume of RPMI 1640 medium 
Trypanosoma cruzi antigens
Protein lysate from T. cruzi amastigotes derived from the Brazil strain was obtained by four freeze/thaw cycles followed by sonication, as previously reported [10] .
IFN-γ enzyme-linked immunosorbent spot (ELISPOT) assays
The number of T. cruzi-specific IFN-γ-producing T-cells was determined by ex vivo ELISPOT assays with a commercial kit (BD Biosciences), as described elsewhere [10] . PBMCs were stimulated with 10 μg/mL of a T. cruzi lysate preparation, with or without IL-7 (Abcam) or IL-27 (R&D), at 50 ng/mL final concentration. Stimulation with 20 ng/mL of PMA (Sigma) plus 500 ng/mL ionomycin (Sigma) or medium alone, with or without cytokines, was performed as a positive or negative control, respectively. The number of specific IFN-γ-secreting cells was calculated by subtracting the value of the wells containing media alone. Responses were considered positive when a minimum of 10 spots/4×10 5 PBMCs were present per well, and this number was at least twice the number present in wells with medium alone. Thereafter, subjects who showed positive IFN-γ ELISPOT responses were referred as "IFN-γ producers" and those with ELISPOT responses below background levels were referred as "IFN-γ nonproducers". 
Monoclonal antibodies, gating strategies and data acquisition
Intracellular IFN-γ staining assays
For sixteen to twenty hours, 4×10 6 PBMCs were incubated with 15 μg/mL of lysate preparation [10] or media alone plus 1 μg/mL CD28/CD49d (BD Biosciences) at 37˚C in a CO 2 incubator. Brefeldin A (10 μg/mL; Sigma) was added for the last 5 h of incubation, as previously described [11, 12] . Stimulation with Staphylococcal enterotoxin B (SEB) (1 μg/mL; Sigma Aldrich) served as a positive control. Cells were stained with FV510 and anti-CD4 PB, anti-CD127 Alexa Fluor 647, anti-CD132 PE and anti-PD-1 PE-Cy7 monoclonal antibodies (BD Bioscience) for 30 min on ice followed by fixation and permeabilization for intracellular staining with anti-IFN-γ (AF488) (BD, Bioscience). CD127, CD132 and PD-1 expression levels were quantified in IFN-γ-producing and non-IFN-γ-producing CD4 + T cells.
Measurement of cytokines and sCD127 in serum samples
Serum levels of IL-7, IL-9, IL-21and IL-27(Abcam)and sCD127 (MyBioSource) were measured in duplicate using ELISA kits. Inflammatory cytokines including IL-1β, IL-6, IL-8, IL-9, IL-10, IL-12 and TNF-α, were measured by Cytometric Bead Array (CBA, BD Biosciences) according to the manufacturer's instructions.
In vitro expansion of T. cruzi-specific T cells
Cells ( 3×10 6 ) were plated in 24-well cell-culture plates in a total volume of 1.5 mL complete RPMI with 10% FBS and incubated for 10 days at 37˚C, with 5% CO 2 atmosphere, 99% humidity, along with T. cruzi lysate (10 μg/mL final concentration), in the presence or absence of rhIL-7 or rhIL-27 (25 ng/mL final concentration). On day three, 20 IU/mL of IL-2 (BioLegend) was added to each well. After 10 days, PBMCs were harvested, washed, and resuspended in complete RPMI medium. Cultured PBMCs were tested for the presence of IFN-γ-secreting T cells in response to T. cruzi lysate using ELISPOT assay, by seeding 2×10 5 cultured PBMCs/ well along with 1×10 5 autologous unstimulated cryopreserved PBMCs/well as antigen presenting cells. + T cells based on the expression of CD127 and CD132. IFN-γ producers in patients with cardiac disease (i.e., subjects in the G1, G2 and G3 clinical groups) exhibited lower frequencies of RTE in the CD4 + and CD8 + T-cell compartments compared with IFN-γ nonproducers and uninfected subjects (Fig 2A and 2B ). IFN-γ producers and IFN-γ nonproducers in G0 patients exhibited equally decreased values of CD4 + RTE compared to uninfected subjects (Fig 2A) . In contrast, CD4
Statistical analysis
Results
Lack of IFN-γ-producing cells in response to
cruzi-infected subjects were enriched in the TTE cells compared with uninfected subjects, regardless of the ability of T cells to respond to T. cruzi antigens and the clinical status ( Fig 3A and S1E Fig) . Only IFN-γ producers and IFN-γ nonproducers with no signs of cardiac disease exhibited equally significantly increased levels of TTE cells among CD8 + T cells ( Fig 3B) compared with uninfected subjects.
TTE levels were also slightly increased in patients with cardiac disease (Fig 3B) .
Higher frequencies of T cells with downregulated CD127 expression and PD-1 expression in IFN-γ-producing T cells in response to T. cruzi
We 
Impaired IFN-γ production is associated with increased basal levels of STAT5 phosphorylation and CD25 expression and decreased basal expression of Bcl-2 in T cells
We evaluated the association between IFN-γ secretion capacity in response to T. cruzi and the function of IL-7 receptor as measured using STAT5 phosphorylation and CD25 and Bcl-2 expression in T cells following stimulation with rhIL-7. IFN-γ nonproducers with cardiac disease (i.e., subjects of the G1, G2 and G3 clinical groups) exhibited lower frequencies of phosphorylated STAT5 + (pSTAT5) in CD4 + T cells than IFN-γ producers and uninfected subjects, with severe cardiomyopathy compared with IFN-γ producers and uninfected subjects (Fig 6A) . Most patients exhibited unaltered basal CD25 expression in T CD4 + T cells (Fig 6C) . The basal expression of the activation marker CD25 in CD8 + T cells was increased in IFN-γ nonproducers with cardiac disease compared with IFN-γ producers and uninfected subjects (Fig 6D) , but the upregulation of CD25 after IL-7 stimulation was not drastically impaired in subjects who lacked IFN-γ-producing cells (Fig 6B) . A slight decrease in Bcl-2 expression in response to IL-7 along with decreased basal Bcl-2 expression levels was found in CD4 + and CD8 + T cells of IFN-γ nonproducers compared with IFN-γ producers and uninfected subjects (Fig 6E-6H ).
IFN-γ producers with no signs of cardiac disease exhibited low levels of circulating sCD127
We investigated whether increased serum levels of IL-7 observed in patients with chronic Chagas disease [24] were associated with altered levels of the soluble form of the IL-7R (sCD127) and IFN-γ production. A lower sCD127 concentration was found in IFN-γ producers without signs of cardiac dysfunction than IFN-γ nonproducers and uninfected controls ( Fig 7A) with a strong inverse correlation between sCD127 levels and the number of IFN-γ-producing cells (Fig 7B) . In contrast, no differences were found in IL-7 levels between IFN-γ nonproducers and IFN-γ producers, and a weak inverse correlation was found between IL-7 and sCD127 serum levels (Fig 7C and 7D ).
Serum cytokines involved in regulation of the IL-7/IL7R pathway are altered in chronic Chagas disease
Increased basal levels of T cells expressing phosphorylated STAT5 in IFN-γ nonproducers led us to hypothesize that other cytokines signaling through STAT5, including IL-9, IL-21 and IL-27, and inflammatory cytokines may be altered in these patients. IL-21, IL-27 and IL-6 levels horizontal lines. Black symbols indicate the subjects treated with benznidazole. The responses of T. cruzi-infected subjects were used to determine the IFN-γ producers (P) and IFN-γ nonproducers (NP) based on the ELISPOT assay, as described in Materials and Methods.
Comparisons between P and NP for each clinical group and uninfected subjects were performed using ANOVA followed by Bonferroni's multiple comparisons test.
001. ### p � 0.001 compared to P G0, P G1 and P G2-G3.
https://doi.org/10.1371/journal.pntd.0006998.g001 were not significantly different between IFN-γ producers and IFN-γ nonproducers but varied according to disease severity (Fig 8A-8C, S5 Fig). Patients with a lower degree of cardiac dysfunction exhibited decreased levels of circulating IL-21 and IL-27 compared with patients with more severe disease and uninfected subjects (S5A and S5B Fig) . Patients with severe cardiomyopathy exhibited increased IL-6 levels compared with patients with less severe forms of the disease and uninfected subjects (S5C Fig) . IL-8 levels in patients with no signs of cardiac disease (i.e., the G0 group) were higher in IFN-γ producers than IFN-γ nonproducers and both groups were higher than uninfected subjects (Fig 8D) . IL-6 levels positively correlated with the frequencies of CD4 + and CD8 + memory T cells with unmodulated CD127 (Fig 8E) . In contrast, IL-8 levels positively correlated with the frequencies of CD4 + T cells with downregulated CD127 ( Fig   8F) and inversely associated with sCD127 levels (Fig 8G) . Serum concentrations of IL-1β, IL-9, IL-10, IL-12, and TNF-α were undetectable in most of the evaluated patients (S1 Table) .
Univariate and multivariate analysis of factors associated with T. cruzispecific T-cell responses
Univariate and multivariate analyses were performed to identify independent parameters linked to the ability of T cells to produce (Table 3) . Notably, these associations were not uniform between CD4 + and CD8 + T cells (Tables 2 and 3 ).
Correlation analyzes were performed to evaluate differences in the expression of the parameters evaluated according to the magnitude of T. cruzi-specific responses in the group of IFN-γ producers. The number of IFN-γ CPS in patients in the G0 and G1 groups positively correlated with the percentages of memory CD8 + T cells with unmodulated CD127 (i.e., Table 4 ). The number of IFN-γ CPS in G0 patients also positively associated with the basal expression of Bcl-2 in T cells and inversely associated with IL-7 serum concentration (Table 4 ). An inversely correlation was also observed between IFN-γ CPS and the basal percentages of CD8 + pSTAT5 + in G1 patients (Table 4) . IFN-γ CPS in patients in the G2 and G3 groups positively correlated with the percentages of TTE CD4 + and CD8 + T cells and inversely correlated with CD4 + RTE ( Table 4) .
Low levels of IFN-γ-producing cells cannot be reverted with in vitro treatment with IL-7 or IL-27
We examined whether in vitro treatment of PBMCs with IL-7 or IL-27 enhanced T. cruzi-specific T cell responses in chronic Chagas disease patients. Addition of IL-7 or IL-27 in shortdefined in Materials and Methods. Median values are indicated as horizontal lines. Black symbols indicate subjects treated with benznidazole. Comparison between P and NP for each clinical group and uninfected subjects were performed using ANOVA followed by Bonferroni's multiple comparisons test. � p � 0.05. (A) # p � 0.05 compared with P G0, NP G0, P G1 and P G2-G3; (B) # p � 0.05 compared with P G2-G3; ## p � 0.01 compared with P G0; ### p � 0.01 compared with P G1.
https://doi.org/10.1371/journal.pntd.0006998.g002 term cultures with T. cruzi antigens increased the number of IFN-γ-producing T cells in response to T. cruzi in IFN-γ producers but not IFN-γ nonproducers in patients with no signs of cardiac disease and patients with some degree of cardiac dysfunction. This increase was specific because no changes in the frequencies of T. cruzi-responsive IFN-γ-producing cells were observed in uninfected subjects (Fig 9A and 9B) . A significant expansion of IFN-γ-producing cells were obtained after a 10-day ex vivo culture with T. cruzi antigens following the addition of IL-7 or IL-27 in IFN-γ producers, and IFN-γ-producing cells remained unchanged in IFN-γ nonproducers (Fig 10A and 10B) . Notably, the fold increase in IFN-γ producers with cardiac dysfunction was significantly lower than IFN-γ producers without cardiac disease (Fig 9A and  9B , right panels; Fig 10A and 10B, right panels) .
Discussion
The IL-7/IL-7R signaling pathway is necessary for memory T-cell formation, homeostasis, and self-renewal after resolution of an acute infection. In contrast, T cells fail to develop into selfperformed using ANOVA followed by Dunn's multiple comparisons test. (A) ## p � 0.01 compared to NP G1 and NP G2-G3; ### p � 0.001 compared with P G1 and NP G0; #### p � 0.0001 compared with P G0 and P G2-G3; (B) ## p � 0.001 compared with P G0 and NP G0.
https://doi.org/10.1371/journal.pntd.0006998.g003 renewing, antigen-independent memory T cells during chronic infections, which may be driven by the reduced expression of IL-7R on T cells or a failure to respond efficiently to this cytokine, with a subsequent loss of pathogen-specific T cells [31] [32] [33] [34] [35] [36] . The present study demonstrated that the ability of T cells to secrete IFN-γ in response to T. cruzi was associated with a functional IL-7/IL-7R signaling pathway in memory T cells, high basal expression of Bcl-2, low basal levels of activated T cells, and fewer inhibitory mechanisms on this axis, regardless the clinical stage of the disease. Grouping of patients according to the clinical stage revealed striking differences in the IL-7/IL-7R pathway in IFN-γ producers and IFN-γ nonproducers. The downregulation of IL-7Rα chain expression in memory T cells decayed with increasing disease severity in IFN-γ producers. Notably, the number of IFN-γ producing cells in IFN-γ producers with less severe forms of the disease was inversely associated with the frequency of memory T cells with downregulated CD127, serum levels of IL-7 and the basal frequencies of Black symbols indicate subjects treated with benznidazole. Based on the ELISPOT assay, responses of T. cruzi-infected subjects were used to determine the IFN-γ producers (P) or IFN-γ nonproducers (NP), as described in Materials and Methods. Comparisons between P and NP for each clinical group and uninfected subjects were performed using ANOVA followed by Dunn's multiple comparisons test. and IL-7 (C) were measured using ELISA, and IFN-γ-producing cells were measured using ELISPOT in subjects at different clinical stages of chronic Chagas disease. Spearman's correlation analysis between sCD127 and the T. cruzi-specific IFN-γ production in T. cruzi-infected subjects with no signs of cardiac dysfunction (B). Pearson's correlation analysis between sCD127 and IL-7 in chronic Chagas disease patients (D). Horizontal lines indicate median values. Black symbols indicate subjects treated with benznidazole. Based on the ELISPOT assay, responses of T. cruzi-infected subjects were used to determine the IFN-γ producers (P) or IFN-γ nonproducers (NP), as described in Materials and Methods. Comparisons between P and NP for each clinical group and uninfected subjects were performed using ANOVA followed by Dunn's multiple comparisons test. frequencies of naïve T cells [11, 37] and the low degree of differentiation in IFN-γ-producing cells [13] from individuals chronically infected with T. cruzi subjects.
The increased recruitment of RTE in patients with more severe forms of the disease may be a compensatory mechanism to maintain parasite-specific T cells. Increased IL-7 levels may be responsible for the increased basal levels of pSTAT5 + and CD25 + T cells as part of these compensatory mechanisms to counteract the disruption in the IL-7/IL-7R axis. Fonseca et al. demonstrated high mRNA expression of IL-7 in heart tissues of patients with Chagas disease cardiomyopathy [38] . T. cruzi-infected subjects lacking parasite-specific T-cell responses and showing no signs of cardiac dysfunction still exhibited a functional signature of the IL-7/IL-7R pathway in T cells with STAT5 phosphorylation and CD25 expression in response to IL-7. In contrast, IFN-γ nonproducers with severe cardiomyopathy exhibited an impaired capacity to respond to IL-7. We confirmed that IFN-γ-producing cells in response to T. cruzi exhibited downregulated CD127 expression. IL-7R plays a role in IL-7 signaling during homeostasis, and it is rapidly internalized and recycled to the cell surface without changing T cell phenotype [39] . IL-7R regulation is also controlled at the transcriptional level, and IL-7 and other cytokines suppress IL-7R mRNA expression [40] . The role of the soluble form of IL-7R (sCD127), which is generated by cleavage or alternative splicing [41] , is controversial. Some reports demonstrated the sCD127 inhibits IL-7 activity [19, 21, 42] , and other studies demonstrated that IL-7 in complex with sCD127 delivered a more potent signal to cell-bound IL-7Rs or constituted a reservoir of IL-7 [43] [44] . Increased serum levels of IL-7 in patients with less severe forms of Chagas disease may be induced by the need to maintain T cells during chronic infection because receptor-mediated uptake largely regulates IL-7 levels [45] . Increased IL-7 levels may inhibit IL-7R expression and the release of sCD127, which was supported by the negative correlation between IL-7 and sCD127. This scenario, sustained over time, may lead to desensitization of the pathway, which would result in losses of pathway regulation and T-cell responses, as part of the mechanism of 
IL-7R and T. cruzi-specific T-cell responses
immune exhaustion. This hypothesis was particularly demonstrable in IFN-γ producers with severe cardiomyopathy, who exhibit normal values of IL-7 and sCD127 but decreased responses to IL-7 by the inverse association between IFN-γ producing cells and circulating sCD127. Our previous observations and other studies support the process of immune exhaustion and demonstrated that patients with no signs of cardiac dysfunction exhibited higher frequencies of circulating IFN-γ-producing cells compared with patients with severe cardiomyopathy [10, 14; 46] . Several mechanisms underlying immune exhaustion in chronic Chagas disease were described, including the lack proliferative capacity and downregulation of CD28 and CD3z [47] , increased nitric oxide production concomitant with increased tyrosine nitration [48] and increased expression of inhibitory receptors in T cells [13-14; 49-50] . The present study demonstrated that T.cruzi-induced IFN-γ-producing cells expressed high levels of PD-1, which is a primary inhibitory receptor associated with immune exhaustion [51] [52] [53] , in addition to CTLA-4 and LIR-1 [13] . Our data also demonstrated a positive correlation between IL-6 levels and T cells with unmodulated CD127, which suggests that this inflammatory cytokine blocks T-cell responses to IL-7, as found in HIV infection [22] [23] . Notably, inflammatory cytokines and IL-7 induce the expression of exhaustion and senescence markers, PD-1 and CD57, on T cells [23] . Several studies in subjects chronically infected with T. cruzi revealed that increased levels of IL-6 were associated with cardiac dysfunction [54] [55] [56] [57] , which supports the hypothesis that sustained inflammation in the chronic phase of infection may also alter the homeostatic mechanisms of T-cell maintenance.
IL-8 is a monocyte-derived cytokine that is upregulated by IL-7 [58] , and it was increased in IFN-γ producers with no signs of cardiac dysfunction and inversely associated with sCD127. These results suggest that IL-7 also plays a critical role in the regulation of macrophage cytokine expression. However, other pathways besides IL-7/IL-7R may be involved in the maintenance of T-cell responses. We observed that subjects with a functional IL-7 axis lacked T. cruzi-responsive T cells. The IL-21 and IL-27 levels, which also signal via STAT5 and induce T-cell proliferation and effector function [59] [60] [61] , were also altered in individuals chronically infected with T. cruzi. IL-21 and IL-27 appeared to be consumed in IFN-γ-producers with less severe forms of the disease, which may be another mechanism for the maintenance of T-cell responses.
Exogenous addition of IL-7 or IL-27 did not rescue T. cruzi-responsive IFN-γ-producing T cells in patients with undetectable IFN-γ-producing cells, which suggests that T. cruzi-specific T cells are present but the JAK/STAT pathway is dysfunctional or that T. cruzi-specific T cells were already depleted from the circulation. The higher fold-increase in T. cruzi-specific T cells in IFN-γ responders with no signs of cardiac dysfunction compared with patients with severe disease further supports the hypothesis that impairment in T-cell function is a gradual process. Therefore, our findings provide new insights into the regulation of T cell-mediated immunity against T. cruzi-infection and may aid the design of a vaccine against T. cruzi. However, it is not possible to ascertain whether the impairment of T. cruzi-specific T-cell responses is a cause or a consequence of disease progression. Another limitation of the present study is that the Tcell responses focused solely on responses elicited by a T. cruzi lysate, for which the bulk of the response is CD4 + . Unfortunately, CD8 + T-cell responses elicited by HLA-restricted T. cruziderived epitopes are of very low frequencies [12] . Impaired T-cell responses in chronic Chagas disease are specific for T. cruzi, but these alterations in the IL-7/IL-7R pathway are another example of how this chronic infection affects the general status of the host immune system. Taken together, the present study demonstrated that defective signaling and regulatory mechanisms in the IL-7/IL-7R axis during the chronic phase of Chagas disease may affect the maintenance of parasite-specific IFN-γ-producing cells. Project administration: Susana A. Laucella.
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